Cargando…
1689. Comparison of Antibiotics Use between Patients with Kawasaki Disease and Propensity Score-matched Controls: a Cohort Study of 106,908 Patients
BACKGROUND: The etiology of the Kawasaki disease (KD) has been explained by the influence of infectious agents that interfere with the immune function in genetically susceptible children. In addition of this infectious etiology, we hypothesized that microbial imbalance in the gut from antibiotics us...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677349/ http://dx.doi.org/10.1093/ofid/ofad500.1522 |
_version_ | 1785150108626583552 |
---|---|
author | Kim, Tae-Hwan Shin, Ji Seong Kim, Sin Young Jang, Min Sik Kim, Jihye |
author_facet | Kim, Tae-Hwan Shin, Ji Seong Kim, Sin Young Jang, Min Sik Kim, Jihye |
author_sort | Kim, Tae-Hwan |
collection | PubMed |
description | BACKGROUND: The etiology of the Kawasaki disease (KD) has been explained by the influence of infectious agents that interfere with the immune function in genetically susceptible children. In addition of this infectious etiology, we hypothesized that microbial imbalance in the gut from antibiotics use may be an important etiologic factor. We aimed to assess the association between antibiotics use and the development of KD. METHODS: A population-based, case-control study was performed using data from 2010 to 2019 from the Health Insurance Review and Assessment Service (HIRA) database. Various profiles regarding prior antibiotics use since birth were compared between patients with KD and matched controls. Children aged < 5 years who were diagnosed with initial episode of KD from 2016 to 2019 were identified. Propensity score-matched controls without KD were selected from the general population in a 1:5 ratio. Four separate study cohorts according to four different periods of antibiotics use were created: 1) within 28 days after birth; 2) within 12 months after birth; 3) within 6 months from the index date; and 4) within 12 months from the index date. The occurrence of KD were compared between KD cases and controls. RESULTS: Overall, 17,818 patients with KD and 89,090 matched controls were included in the analysis. Use of antibiotics within 6 months (odds ratio [OR], 1.18; 95% confidence interval [CI], 1.12–1.26) and 12 months (OR, 1.23; 95% CI, 1.14–1.32) from the index date were associated with the development of KD. The association between antibiotics use and KD (OR, 1.26; 95% CI, 1.17–1.37) was most prominent in patients who had received more than three classes of antibiotics within 12 months from the index date. No significant association was observed between the duration of antibiotics use, use of all three major antibiotics classes, or use of any specific antibiotics class and KD. CONCLUSION: The development of KD is associated with antibiotics use. However, evidence suggesting that antibiotics use in the neonatal period or within the first 12 months of life is associated with KD is weak. DISCLOSURES: All Authors: No reported disclosures |
format | Online Article Text |
id | pubmed-10677349 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-106773492023-11-27 1689. Comparison of Antibiotics Use between Patients with Kawasaki Disease and Propensity Score-matched Controls: a Cohort Study of 106,908 Patients Kim, Tae-Hwan Shin, Ji Seong Kim, Sin Young Jang, Min Sik Kim, Jihye Open Forum Infect Dis Abstract BACKGROUND: The etiology of the Kawasaki disease (KD) has been explained by the influence of infectious agents that interfere with the immune function in genetically susceptible children. In addition of this infectious etiology, we hypothesized that microbial imbalance in the gut from antibiotics use may be an important etiologic factor. We aimed to assess the association between antibiotics use and the development of KD. METHODS: A population-based, case-control study was performed using data from 2010 to 2019 from the Health Insurance Review and Assessment Service (HIRA) database. Various profiles regarding prior antibiotics use since birth were compared between patients with KD and matched controls. Children aged < 5 years who were diagnosed with initial episode of KD from 2016 to 2019 were identified. Propensity score-matched controls without KD were selected from the general population in a 1:5 ratio. Four separate study cohorts according to four different periods of antibiotics use were created: 1) within 28 days after birth; 2) within 12 months after birth; 3) within 6 months from the index date; and 4) within 12 months from the index date. The occurrence of KD were compared between KD cases and controls. RESULTS: Overall, 17,818 patients with KD and 89,090 matched controls were included in the analysis. Use of antibiotics within 6 months (odds ratio [OR], 1.18; 95% confidence interval [CI], 1.12–1.26) and 12 months (OR, 1.23; 95% CI, 1.14–1.32) from the index date were associated with the development of KD. The association between antibiotics use and KD (OR, 1.26; 95% CI, 1.17–1.37) was most prominent in patients who had received more than three classes of antibiotics within 12 months from the index date. No significant association was observed between the duration of antibiotics use, use of all three major antibiotics classes, or use of any specific antibiotics class and KD. CONCLUSION: The development of KD is associated with antibiotics use. However, evidence suggesting that antibiotics use in the neonatal period or within the first 12 months of life is associated with KD is weak. DISCLOSURES: All Authors: No reported disclosures Oxford University Press 2023-11-27 /pmc/articles/PMC10677349/ http://dx.doi.org/10.1093/ofid/ofad500.1522 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Abstract Kim, Tae-Hwan Shin, Ji Seong Kim, Sin Young Jang, Min Sik Kim, Jihye 1689. Comparison of Antibiotics Use between Patients with Kawasaki Disease and Propensity Score-matched Controls: a Cohort Study of 106,908 Patients |
title | 1689. Comparison of Antibiotics Use between Patients with Kawasaki Disease and Propensity Score-matched Controls: a Cohort Study of 106,908 Patients |
title_full | 1689. Comparison of Antibiotics Use between Patients with Kawasaki Disease and Propensity Score-matched Controls: a Cohort Study of 106,908 Patients |
title_fullStr | 1689. Comparison of Antibiotics Use between Patients with Kawasaki Disease and Propensity Score-matched Controls: a Cohort Study of 106,908 Patients |
title_full_unstemmed | 1689. Comparison of Antibiotics Use between Patients with Kawasaki Disease and Propensity Score-matched Controls: a Cohort Study of 106,908 Patients |
title_short | 1689. Comparison of Antibiotics Use between Patients with Kawasaki Disease and Propensity Score-matched Controls: a Cohort Study of 106,908 Patients |
title_sort | 1689. comparison of antibiotics use between patients with kawasaki disease and propensity score-matched controls: a cohort study of 106,908 patients |
topic | Abstract |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677349/ http://dx.doi.org/10.1093/ofid/ofad500.1522 |
work_keys_str_mv | AT kimtaehwan 1689comparisonofantibioticsusebetweenpatientswithkawasakidiseaseandpropensityscorematchedcontrolsacohortstudyof106908patients AT shinjiseong 1689comparisonofantibioticsusebetweenpatientswithkawasakidiseaseandpropensityscorematchedcontrolsacohortstudyof106908patients AT kimsinyoung 1689comparisonofantibioticsusebetweenpatientswithkawasakidiseaseandpropensityscorematchedcontrolsacohortstudyof106908patients AT jangminsik 1689comparisonofantibioticsusebetweenpatientswithkawasakidiseaseandpropensityscorematchedcontrolsacohortstudyof106908patients AT kimjihye 1689comparisonofantibioticsusebetweenpatientswithkawasakidiseaseandpropensityscorematchedcontrolsacohortstudyof106908patients |